Influence of Bubble Size Distribution on the Echogenicity of Ultrasound Contrast Agents

Jean-Marie Gorce, Marcel Arditi, Michel Schneider

Investigative Radiology · 2000 · 410 citations · 13 references

Concepts

TL;DR

SonoVue (BR1) is a contrast agent with a bubble size distribution ranging from ~0.7 to 10 µm, and its acoustic response was modeled and validated against experimental data. The study aimed to determine how different bubble size classes contribute to SonoVue’s echogenicity in fundamental acoustic imaging modes. A validated acoustic model was used to simulate the response of a standard SonoVue batch as the sum of non‑overlapping size‑class contributions, and the simulation was first verified against a standard bubble size distribution. Simulations showed that bubbles smaller than 2 µm, which make up 60 % of the count, contribute only 5 % of the gas volume and 20 % of acoustic efficacy, whereas bubbles 3–9 µm provide 80 % of echogenicity, indicating that bubble volume—not count—is a better indicator of SonoVue efficacy and that a diameter threshold near 2.

Abstract

To study the relative contributions of different bubble size classes to SonoVue's echogenicity in fundamental acoustic imaging modes. SonoVue is a contrast agent, previously known as BR1, with a bubble size distribution extending from approximately 0.7 to 10 microm.A model for the acoustic response of SonoVue was determined and validated for a set of experimental data. This model was used to simulate the acoustic response of a standard batch of SonoVue as the sum of responses of non-overlapping bubble size classes.The simulation was first validated for a standard SonoVue bubble size distribution. When this distribution was considered as five size classes with equal numbers of bubbles, it was found that bubbles smaller than 2 microm accounted for 60% of the total number but contained only 5% of the total gas volume. The simulation results indicated marked differences in the acoustic contributions from these classes, with 80% of the acoustic efficacy provided by bubbles 3 to 9 microm in diameter. The study also compared bubble distributions in number, surface, and volume, with the distribution computed in terms of acoustic efficacy.This study shows why bubble volume is a much better indicator of SonoVue's efficacy than is bubble count. A low threshold in diameter was found for SonoVue microbubbles at approximately 2 microm, under which size bubbles do not contribute appreciably to the echogenicity at medical ultrasound frequencies.

References

13